DeepMed Research

Germans Trias i Pujol Hospital

🇪🇸Spain

Country: 🇪🇸Spain

Ownership: Private

Employees: -

Market Cap: -

Website

Clinical Trials

Clinical Trial to Study 4 Different Doses of the Vaccine RUTI in Healthy Volunteers

Phase 1

Completed

Conditions: Latent Tuberculosis Infection
Tuberculosis

Interventions: Biological: RUTI
Biological: placebo of the vaccine RUTI

First Posted Date: 2007-10-18

Last Posted Date: 2009-05-27

Lead Sponsor: Germans Trias i Pujol Hospital

Target Recruit Count: 24

Registration Number: NCT00546273

Locations: 🇪🇸
Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain
🇪🇸
Pharmacology Department. Hospital Universitari Germans Trias i Pujol., Badalona, Barcelona, Spain
🇪🇸
Experimental Tuberculosis Unit. Fundació Institut per la Investigació Germans Trias i Pujol, Badalona, Barcelona, Spain

Peginterferon Alfa-2a, Ribavirin and Epoetin β in Coinfected Patients HCV/HIV Not Responding to Previous Treatment Regimens

Phase 4

Completed

Conditions: Hepatitis C
HIV Infections

Interventions: Drug: Peginterferón alfa-2a (40 KD) (Pegasys®) 180 ug/week
Drug: Ribavirin (Copegus®) 1600 mg/day
Drug: Epoetin β (450 UI/kg/week)

First Posted Date: 2007-05-07

Last Posted Date: 2019-12-05

Lead Sponsor: Germans Trias i Pujol Hospital

Target Recruit Count: 10

Registration Number: NCT00470210

Locations: 🇪🇸
Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain
🇪🇸
Hospital del Mar, Barcelona, Spain

Saquinavir/Ritonavir in Single Therapy as Maintenance Treatment

Phase 4

Completed

Conditions: HIV Infections

First Posted Date: 2006-09-21

Last Posted Date: 2019-12-04

Lead Sponsor: Germans Trias i Pujol Hospital

Target Recruit Count: 30

Registration Number: NCT00379405

Locations: 🇪🇸
Hospital del Sant Pau., Barcelona, Spain
🇪🇸
Germans Trias i Pujol University Hospital, Badalona, Barcelona, Spain

Viral Kinetics of Treatment With Peginterferon Alpha-2a, Ribavirin and Epoetin β in Patients Coinfected HCV/HIV

Phase 4

Completed

Conditions: HIV Infections

Interventions: Drug: Peginterferon alfa-2a + Ribavirin for 12 weeks
Drug: Peginterferon alfa-2a, Ribavirin, epoetin-β

First Posted Date: 2006-07-26

Last Posted Date: 2019-12-04

Lead Sponsor: Germans Trias i Pujol Hospital

Target Recruit Count: 74

Registration Number: NCT00356486

Locations: 🇪🇸
Hospital de Donostia, San Sebastián, Donostia, Spain
🇪🇸
Hospital General Universitario de Alicante, Alicante, Spain
🇪🇸
Hospital del Mar, Barcelona, Spain

and more 9 locations

Immuno-Virological Efficacy of Combination With Trizivir +Tenofovir in Multiresistant HIV Patients

Phase 4

Terminated

Conditions: HIV Infections

Interventions: Drug: Trizivir (AZT+3HT+Abacavir) twice daily
Drug: Viread (300 mg Tenofovir disoproxil fumarate) once daily

First Posted Date: 2006-07-26

Last Posted Date: 2008-01-29

Lead Sponsor: Germans Trias i Pujol Hospital

Target Recruit Count: 24

Registration Number: NCT00356616

Locations: 🇪🇸
H.U. Germans Trias i Pujol, Badalona, Barcelona, Spain

Study to Evaluate the Influence of Nevirapine to Atazanavir in Steady State Equilibrium in HIV Patients

Phase 4

Completed

Conditions: HIV Infections

Interventions: Drug: Atazanavir (Reyataz)
Drug: Ritonavir (Norvir)
Drug: Nevirapine (Viramune)

First Posted Date: 2006-07-25

Last Posted Date: 2019-12-04

Lead Sponsor: Germans Trias i Pujol Hospital

Target Recruit Count: 14

Registration Number: NCT00355719

Locations: 🇪🇸
Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain
🇪🇸
Hospital Sant Jaume de Calella, Calella, Barcelona, Spain

Influence of Atorvastatin on Viral Replication During Antiretroviral Treatment Interruption

Phase 4

Terminated

Conditions: HIV Infections

Interventions: Drug: Atorvastatin 40 mg/Atorvastatin 80 mg

First Posted Date: 2006-07-21

Last Posted Date: 2014-03-20

Lead Sponsor: Germans Trias i Pujol Hospital

Target Recruit Count: 5

Registration Number: NCT00355251

Locations: 🇪🇸
Germans Trias i Pujol Hospital, Badalona, Barcelona, Spain

Study on the Effect of Kaletra + Nevirapine as Maintenance Bitherapy Compared to a Triple Therapy Including Kaletra + Analogues in HIV Patients

Phase 4

Completed

Conditions: HIV Infections

First Posted Date: 2006-06-12

Last Posted Date: 2008-02-29

Lead Sponsor: Germans Trias i Pujol Hospital

Target Recruit Count: 67

Registration Number: NCT00335686

Locations: 🇪🇸
Hospital C. Universitario Virgen de la Victoria, Malaga, Málaga, Spain
🇪🇸
Hospital Nuestra Señora del Rosell, Cartagena, Murcia, Spain
🇪🇸
Hospital Virgen del Toro, Mahón, Menorca, Spain

and more 21 locations

To Determine if There Are Pharmacokinetic Interactions at Plasma or Intracellular Level Between Nucleosides and Tenofovir

Phase 4

Completed

Conditions: HIV

Interventions: Drug: Patients in treatment with 3TC + TDF + LPV/rtv, stop tenofovir during 4 weeks
Drug: Patients in treatment with ABV + TDF + LPV/rtv, stop tenofovir during 4 weeks
Drug: Patients in treatment with 3TC + ABV + TDF+ LPV/rtv, stop TDF during 4 weeks

First Posted Date: 2006-06-09

Last Posted Date: 2008-09-08

Lead Sponsor: Germans Trias i Pujol Hospital

Target Recruit Count: 32

Registration Number: NCT00335192

Locations: 🇪🇸
Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain

Study to Evaluate the Effectiveness of ABC+3TC +EFV in Once-Daily Regimens Versus KLT in Twice-Daily Regimens in Naive HIV Patients

Phase 3

Completed

Conditions: HIV Infections

Interventions: Drug: Kivexa

First Posted Date: 2006-04-26

Last Posted Date: 2008-01-29

Lead Sponsor: Germans Trias i Pujol Hospital

Target Recruit Count: 126

Registration Number: NCT00318123

Locations: 🇪🇸
Hospital Central de Asturias, Asturias, Oviedo, Spain
🇪🇸
Hopsital Gregorio Marañón, Madrid, Spain
🇪🇸
Hospital Virgen Macarena, Sevilla, Spain

and more 17 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy